↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$17.9MSold on the market
1Companies
Sep 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202621:35 | Sep 17, 2026from Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | EVP, CHIEF COMMERCIAL OFFICER | S · Sell10b5-1 | $63.06 | −283,189 | 117,066 | -71% | −$17.9M | ||
| Sep 17, 202621:35 | Sep 17, 2026from Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | EVP, CHIEF COMMERCIAL OFFICER | M · Exercise10b5-1 | $15.69 | +258,189 | 125,348 | — | $4.1M |